logo-loader
viewProtomer Technologies Inc.

Protomer Technologies developing an insulin injectable alternative for diabetes patients

Protomer Technologies Inc CEO Alborz Mahdavi joined Proactive at the Biotech Showcase 2020 in San Francisco. The California-based, privately-held biotechnology company is developing a glucose responsive insulin that can automatically adjust its activity in the body throughout the day.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

NQ Minerals' David Lenigas says 44% boost to Hellyer production is 'biggest...

NQ Minerals PLC's (LON:NQMI) tells Proactive London's Andrew Scott that the plant upgrade at the Hellyer Gold Mine in Tasmania has resulted in a 44% increase in production. The enhancements, done six months ahead of expectation, have resulted in hourly production of 150 tonnes, which equates to...

5 hours, 20 minutes ago

2 min read